InsiderTrades

Form 4 for PRVA Privia Health Group, Inc.

Accepted 2022-11-22 00:00:00 ET · period of report 2022-11-21 · accession 0001759655-22-000196 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-11-22 2022-11-21 PRVA Mountcastle David EVP, CFO M - OptEx $2.00 +55.9K 147.2K +61% +$111.7K
DM 2022-11-22 2022-11-21 PRVA Mountcastle David EVP, CFO M - OptEx $2.00 -55.9K 25.5K -69% -$111.7K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, $0.01 par value per share 2022-11-21 M A 55,867 $2.00 147,238 D — —
2 Derivative Stock Option (Right to Purchase) 2022-11-21 M D 17,244 $2.00 17,244 D $2.00 · — to 2029-03-20 17,244 Common Stock (F1) All of the stock options are fully vested and exercisable.
3 Derivative Stock Option (Right to Purchase) 2022-11-21 M D 6,666 $2.00 10,833 D $2.00 · — to 2030-09-07 6,666 Common Stock (F3) Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported on this Form 4, 13,333 of the stock options are fully vested and exercisable. 4,166 of the stock options will vest on September 8, 2023.
4 Derivative Stock Option (Right to Purchase) 2022-11-21 M D 6,438 $2.00 8,931 D $2.00 · — to 2029-12-03 6,438 Common Stock (F2) Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported on this Form 4, 12,876 of the stock options are fully vested and exercisable. 2,493 of the stock options will vest December 4, 2022.
5 Derivative Stock Option (Right to Purchase) 2022-11-21 M D 25,519 $2.00 25,518 D $2.00 · — to 2028-08-27 25,519 Common Stock (F1) All of the stock options are fully vested and exercisable.